As a Swiss company, ActivCell AG places great value on a transparent and sustainable value-added chain. This is why the company develops and produces all devices in Switzerland.
ActivCell AG provides services and sells products in the field of electrotherapy to different markets. ActivCell AG uses extremely sophisticated technology to produce devices that operate in medium- and high-frequency ranges, thus causing a therapeutic depth effect in the organism.
A high level of quality and constant technological development are further key values of ActivCell AG. Our products are continuously improved thanks to close cooperation with specialists from science and practice.
Sport horses are regularly exposed to high levels of physical stress. Great demands are made of their whole musculoskeletal system, which means that injuries are a common occurrence in equine sports.
ActivCell AG developed the EquCellpen for horses. It allows pain-free and relaxing treatment of pain, and helps with rehabilitation. It is a non-invasive and drug-free alternative to conventional forms of treatment, and can be used as the main form of treatment or as supplementary treatment to other alternative therapies.
The main priority for ActivCell AG is the horses’ well-being: EquCelltherapy means that horses can be effectively and efficiently treated without their well-being suffering in any way. The therapy is completely pain-free for the animals and has a relaxing effect.
The battery-operated devices allow wireless operation that applies electromagnetic waves. The main effects consist of an increase in circulation, stimulation of metabolism, and pain relief. The EquCellpen is 90% Swiss-made. ActivCell AG thus guarantees premium quality in terms of the product and its ergonomic design.
Comprehensively trained specialists are required to ensure that EquCelltherapy can have a specific and useful effect. ActivCell AG guarantees the correct use of its devices through a supplementary training course that enables therapists to be trained and supported in their use of the product.
Ruedi und Peter Weber, the founders of ActivCell AG Following surgery, Ruedi Weber suffered with intense pain in his hand and foot, which also resulted in cognitive impairment. After the various forms of treatment prescribed by physicians were unsuccessful, a friend recommended that Ruedi Weber try high-frequency therapy to stimulate cellular metabolism. The joint pain started to improve rapidly. Impressed by the therapy, Ruedi Weber recommended high-frequency therapy to his brother, Peter Weber, who was suffering from intense back pain. Having already undergone two operations on his back, Peter Weber was facing the decision of whether to have further surgery. Ruedi Weber advised him not to and instead recommended electrotherapy. After just ten treatment sessions, Peter Weber was pain-free and totally convinced by the method.
Overwhelmed by numerous cases of successful therapy, the brothers carried out more detailed research and realised that many doctors and therapists have not looked into this form of electrotherapy and do not use it. This meant that there were also no modern devices available. Ruedi and Peter Weber had both been treated with a large, bulky, rather unprofessional device that was plugged in with a cable and only had a few possible settings. Determined to change this, Ruedi and Peter Weber - together with engineers from the fields of physics, electrical and mechanical engineering, and product design - founded ActivCell AG with the aim of developing a device that could be used in the medical field and of researching the scientific mode of operation of cellular metabolism under electrotherapy stimulation.
ActivCell AG is delighted with the newly developed EquCellpen that is initially being used in the field of veterinary medicine. The company aims to adapt the pen to further markets so it can also be used in human medicine.
Géraldine Wymann has enjoyed spending time with horses since she was just six years old. She showed a particular interest in show jumping and started riding her horse competitively. She had to learn that injuries can cause sudden and serious illness in horses, and that this can sometimes mean the end of the animal's involvement in sport. There are frequent diagnoses of, for example, osteoarthritis, which is considered to be incurable. The last thing owners want to hear is their vet making a diagnosis of this kind, which can shatter hopes.
Géraldine Wymann came into contact with ActivCell AG while working for her bachelor's degree. As the EquCellpen was developed specifically for horses, Géraldine Wymann's interest was piqued at once. Although the area of application of the EquCellpen corresponds to conditions that horses suffer from frequently, this form of high-frequency therapy does not yet exist in veterinary medicine either. Impressed by the mode of action of the EquCellpen and its suitability for horses, Géraldine Wymann decided to join ActivCell AG. Géraldine Wymann is responsible for all operative activities, in particular in the field of marketing and sales.
Philipp Achermann has many years of professional experience in the fields of tourism, healthcare, office requirements, and in manufacturing enterprises. In his career, he has held various managerial roles in sales, marketing and product management. His core competence lies in branding and brand management, as well as in sales, which is the area he received his master's degree in.
Today he is responsible for marketing and sales at ActivCell and EquCell. Philipp Achermann also has an affinity to horses: his father was an enthusiastic dressage rider. As a child, Mr Achermann rode himself and is still a member of the regional cavalry association.
Wireless electrotherapy for animals (horses, dogs & cats). The EquCellpen is a therapeutic device for horses that uses medium and high frequencies. Electromagnetic waves activate cells in the organism. The specially made glass tip bundles electrostatic impulses and transmits them into the body. The depth effect then develops in the various layers of skin. This disturbs and interrupts biological cell communication, which boosts the body's own self-healing process.